Figures computed from official regulatory filings — .
Analysttarget 12.43 USD (+109%) · consensus 4.86/5 · 7 buy · 0 hold · 0 sell
Ownershipinsiders 24.45% · institutions 47.8% · short 6.4% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Orchestra BioMed Holdings, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company's flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure; and Virtue Sirolimus AngioInfusion Balloon for the treatment of atherosclerotic artery disease. It also develops Cardiac Neuromodulation Therapy for heart failure, or potential treatment of clinical indications, such as urology or osteoarthritis; and CNT-HF, a bioelectronic product candidate that aims to reduce chronic sympathetic nervous system activity in heart failure. In addition, the company offers FreeHold devices and additional minimally invasive surgery enabling devices; and Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and upper gastrointestinal endoscopy procedures. It has a collaboration agreement with Medtronic, Inc. for the development of AVIM therapy for the treatment of HTN in pacemaker-indicated patients; and a strategic collaboration with Terumo Corporation and Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral vascular disease. Orchestra BioMed Holdings, Inc. was founded in 2018 and is headquartered in New Hope, Pennsylvania.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
37 buys15 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Sherman Darrentrack record | Sell | $95.4K | Unusual size | SEC |
| Hochman David Ptrack record | Other | $19.1K | SEC |
| Hochman David Ptrack record | Other | $19.1K | SEC |
| Hochman David Ptrack record | Buy | $47.9K | conv 46Unusual size | SEC |
| Sherman Darrentrack record | Sell | $74.1K | Unusual size | SEC |
| Taylor Andrew Lawrencetrack record | Other | $16.2K | SEC |
| Sherman Darrentrack record | Other | $25.9K | SEC |
| Aiello Joshua | Other | $1.1K | SEC |
| Sherman Darrentrack record | Buy | $10.7K | conv 40First in 12mo | SEC |
| Cleary Chris | Other | $18.7K | SEC |
| Mack John Prosper | Other | $21.6K | SEC |
| Pacitti David | Other | $16.6K | SEC |
| Fain Eric S | Other | $22.7K | SEC |
| Sherman Darrentrack record | Sell | $61.4K | SEC |
| Sherman Darrentrack record | Sell | $64K | Unusual size | SEC |
| Aryeh Jasontrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Fain Eric S | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Yanchik Connealy Pamelatrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Pacitti David | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Yanchik Connealy Pamelatrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Fain Eric S | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Fain Eric S | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mack John Prosper | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Mack John Prosper | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Cleary Chris | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |